Contact this trialFirst, we need to learn more about you.
Protein Kinase Inhibitor
Dabrafenib +3 More for Melanoma
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing two different combinations of drugs to treat patients with stage III-IV melanoma that has spread or can't be removed by surgery. The first combination is nivolumab with trametinib and dabrafenib. The second combination is encorafenib with binimetinib. The trial will compare how well the two combinations work and what side effects they cause.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.